anti-PD-L1 vaccine (Imugene)

N/A

Report date: 2025/06/11 10:22:20

Base Information

Drug Nameanti-PD-L1 vaccine (Imugene)
Drug Alias NamePD-L1 checkpoint inhibitor vaccine (Imugene)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes stimulantsProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImugene Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A